Science Explorer Back to mapMap
Discussion
Research facility · Leiden · Netherlands

Top Institute Pharma

Research works
10
fractional, all time
Citations
235
22.6 per fractional work
Top-10% rate
9.5%
all institutions 10.0%
Open access
42%
world 40%
International
30%
world 18%

Not ranked overall: Top Institute Pharma is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Top Institute Pharma work in?

In all years, 35% of research at Top Institute Pharma is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (35%), Economics, Econometrics and Finance (24%), Biochemistry, Genetics and Molecular Biology (17%). It does 1.3× the world's share of Life Sciences.

Health Sciences: 4 fractional works · 35.0% of its workMedicine: 4 fractional works · 35.0% of its workPhysiology: 1 fractional works · 7.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 5.3% of its workNephrology: 0 fractional works · 4.8% of its workPharmacology: 0 fractional works · 3.9% of its workReproductive Medicine: 0 fractional works · 3.5% of its workImmunology and Allergy: 0 fractional works · 3.2% of its workOncology: 0 fractional works · 2.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.4% of its workEpidemiology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.2% of its workLife Sciences: 3 fractional works · 28.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 17.3% of its workMolecular Biology: 1 fractional works · 11.4% of its workGenetics: 1 fractional works · 5.9% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 7.3% of its workPharmacology: 0 fractional works · 4.7% of its workToxicology: 0 fractional works · 2.0% of its workPharmaceutical Science: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 4.3% of its workImmunology: 0 fractional works · 4.3% of its workSocial Sciences: 3 fractional works · 24.4% of its workEconomics, Econometrics and Finance: 3 fractional works · 24.4% of its workEconomics and Econometrics: 3 fractional works · 24.4% of its workPhysical Sciences: 1 fractional works · 11.7% of its workEngineering: 0 fractional works · 4.1% of its workBiomedical Engineering: 0 fractional works · 4.1% of its workMaterials Science: 0 fractional works · 3.9% of its workBiomaterials: 0 fractional works · 3.9% of its workChemistry: 0 fractional works · 1.7% of its workOrganic Chemistry: 0 fractional works · 1.7% of its workComputer Science: 0 fractional works · 1.4% of its workComputational Theory and Mathematics: 0 fractional works · 1.4% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.2% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.2% of its workALL ITS WORKTop InstitutePharma10fractional works, all years
Life Sciences29%Physical Sciences12%Health Sciences35%Social Sciences24%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine435.0%
    1. Biochemistry, Genetics and Molecular Biology217.3%
    2. Pharmacology, Toxicology and Pharmaceutics17.3%
    3. Immunology and Microbiology04.3%
    1. Economics, Econometrics and Finance324.4%
    1. Engineering04.1%
    2. Materials Science03.9%
    3. Chemistry01.7%
    4. Computer Science01.4%
    5. Mathematics00.4%
    6. Environmental Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Top Institute Pharma?

    The most cited paper from Top Institute Pharma is "How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider" (Huub Schellekens, Sven Stegemann, Vera Weinstein et al., 2013), with 121 citations. Next come "The therapeutic equivalence of complex drugs" (111) and "How to screen non-viral gene delivery systems in vitro?" (110).

    Most cited papers
    #PaperReleasedCitations
    1 How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider Huub Schellekens, Sven Stegemann, Vera Weinstein et al. · The AAPS Journal Open access 25 Sep 2013 121
    2 The therapeutic equivalence of complex drugs Huub Schellekens, Ety Klinger, Stefan Mühlebach et al. · Regulatory Toxicology and Pharmacology 15 Oct 2010 111
    3 How to screen non-viral gene delivery systems in vitro? Ethlinn V.B. van Gaal, Roel van Eijk, Ronald S. Oosting et al. · Journal of Controlled Release 10 May 2011 110
    4 The similarity question for biologicals and non-biological complex drugs Daan J.A. Crommelin, Vinod P. Shah, Imre Klebovich et al. · European Journal of Pharmaceutical Sciences Open access 25 Apr 2015 69
    5 Flow cytometry for rapid size determination and sorting of nucleic acid containing nanoparticles in biological fluids Ethlinn V.B. van Gaal, G. Th. Spierenburg, Wim E. Hennink et al. · Journal of Controlled Release 23 Sep 2009 61
    All 30 most cited papers, with filters and sorting

    Which research topics does Top Institute Pharma publish most on?

    By volume: Pharmaceutical Economics and Policy, RNA Interference and Gene Delivery, Biosimilars and Bioanalytical Methods and Diet and metabolism studies.

    1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
    2. 2 RNA Interference and Gene Delivery Molecular Biology 1 works
    3. 3 Biosimilars and Bioanalytical Methods Immunology 0 works
    4. 4 Diet and metabolism studies Physiology 0 works
    5. 5 Renal function and acid-base balance Nephrology 0 works
    6. 6 Drug-Induced Adverse Reactions Pharmacology 0 works
    7. 7 Nanoparticle-Based Drug Delivery Biomaterials 0 works
    8. 8 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
    9. 9 Science, Research, and Medicine Reproductive Medicine 0 works
    10. 10 Virus-based gene therapy research Genetics 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available42.5%not open57.5%

    World: 40% of research is openly available.

    with international co-authors29.9%domestic only70.1%

    World: 18% is written across borders.

    How has Top Institute Pharma's research output changed?

    20102015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Other research institutions in Leiden

    All research institutions in Leiden

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Top Institute Pharma. Posts are plain text and can be reported.